In conclusion, our present findings expand the concept that VC may be a contributor to as well as a consequence of the pathophysiology of congestive states such as HF and CKD through a release of ET‐1 that is time and dose dependent in nature. This evidence concerns the gene EDN1 and chronic kidney disease.